摘要:
A cephem compound of the formula: wherein R ' is amino substituted thiazolyl which may have halogen(s), protected amino substituted thiazolyl which may have halogen(s), lower alkylamino substituted thiazolyl, amino substituted thiadiazolyl, protected amino-substituted thiadiazolyl, amino substituted pyridyl, protected amino substituted pyridyl, furyl, thiazolyl, thiadiazolyl, phenyl, or naphthyl, R 2 is carboxy(lower)alkyl or protected carboxy(lower)-alkyl, R 3 is lower alkylthio, and R 4 is carboxy or protected carboxy, and pharmaceutically acceptable salts thereof, and processes for their preparation, and also a pharmaceutical composition comprising, as an active ingredient, the above compound or its pharmaceutically acceptable salt. The invention also relates to intermediate compounds.
R' is carboxy(lower)alkyl or protected carboxy(lower)-alkyl, R 2 is carboxy or protected carboxy, R 3 is hydrogen or lower alkyl, and R 4 is lower alkyl, lower alkoxy, acyloxymethyl, lower alkylthiomethyl, lower alkoxymethyl, halogen, lower alkenyl or hydrogen,
and pharmaceutically acceptable salts thereof, and processes for the preparation thereof and also an antibacterial composition comprising the above compound in association with pharmaceutically acceptable carriers. The invention further relates to intermediate compounds of the formula and the preparation thereof.
摘要翻译:其中R 1为羧基(低级)烷基或保护的羧基(低级)烷基,R 2为羧基或被保护的羧基,R 3为氢或 低级烷基和... R 4是低级烷基,低级烷氧基,酰氧基甲基,低级烷硫基甲基,低级烷氧基甲基,卤素,低级烯基或氢,及其药学上可接受的盐,以及其制备方法以及抗菌组合物, 上述化合物与药学上可接受的载体结合。 本发明还涉及下式的中间体化合物及其制备方法。
R ' is amino substituted thiazolyl which may have halogen(s),
protected amino substituted thiazolyl which may have halogen(s), lower alkylamino substituted thiazolyl, amino substituted thiadiazolyl, protected amino-substituted thiadiazolyl, amino substituted pyridyl, protected amino substituted pyridyl, furyl, thiazolyl, thiadiazolyl, phenyl, or naphthyl,
R 2 is carboxy(lower)alkyl or protected carboxy(lower)-alkyl, R 3 is lower alkylthio, and R 4 is carboxy or protected carboxy,
and pharmaceutically acceptable salts thereof, and processes for their preparation, and also a pharmaceutical composition comprising, as an active ingredient, the above compound or its pharmaceutically acceptable salt. The invention also relates to intermediate compounds.
摘要:
7-acylamino-3-vinylcephalosporanic acid derivatives of the formula: in which R 1 is amino-substituted-heterocyclic group which may have halogen, protected amino-substituted-heterocyclic groug which may have halogen, or a group of the formula: wherein R 3 is lower alkyl, R 2 is carboxy or a protected carboxy group, A is lower alkylene which may have certain substituents and pharmaceutically acceptable salt thereof and processes fortheir preparation and also a pharmaceutically composition comprising, as an effective ingredient, the above compound in association with pharmaceutically acceptable carriers. The invention also relates to the starting compounds and other starting compounds and their preparation.
摘要:
7-acylamino-3-substituted cephalosporanic acid derivatives of the formula: in which R 1 is a group of the formula: wherein R 4 is lower alkyl and
R 5 is amino or a protected amino group, R 2 is lower alkoxymethyl, lower alkylthiomethyl or lower alkenylthiomethyl, R 3 is carboxy or a protected carboxy group, and A is lower alkylene which may have certain substituents
and pharmaceutically acceptable salt thereof and processes for their preparation and also a pharmaceutically composition comprising, as an effective ingredient, the above compound in association with pharmaceutically acceptable carriers. The invention also relates to the starting compounds and their preparation.
R' is amino or a protected amino group, Z is N or CH, R 2 is an organic group, and R is a group of the formula :
(in which R 3 and R 4 are each lower alkyl, or R 3 and R 4 are linked together to form C 3 -C 6 alkylene, A is lower alkylene, and R 5 is hydroxy or a protected hydroxy group) or a group of the formula : (in which R 6 is lower alkyl. R 7 and R 8 are each hydroxy or a protected hydroxy group, and Y is N or CH), and a pharmaceutically acceptable salt thereof, processes for their preparation and pharmaceutical compositions comprising them as an active ingredient. The invention relates also to intermediates of the formula and their preparation.
摘要:
Carboxylic acid derivative of the formula in which
R 1 is amino-substituted-heterocyclic group which may have halogen, protected amino-substituted-heterocyclic group which may have halogen, or a group of the formula: wherein R 3 is lower alkyl, A 13 is lower alkylene having a group of the formula: = N-OR h 4 R e is carboxy or a protected carboxy group, or a salt thereof and process for the preparation thereof.
摘要翻译:其中R 1是可以具有卤素的氨基取代的杂环基的式R 1 -A 1 3 3 -R e(5-cir--b)的羧酸衍生物,被保护的氨基 可以具有卤素的取代杂环基或下式的基团:其中R 3为低级烷基的基团,A 1'3为具有下式基团的低级亚烷基:= N-ORh R 5是羧基或保护的羧基或其盐及其制备方法。